期刊文献+

动物microRNA-181的功能与应用前景 被引量:3

The function and application of animal microRNA-181
下载PDF
导出
摘要 mieroRNA(miRNA)是一类短的、进化上高度保守的非蛋白编码RNA,长度一般为17~25个核苷酸,通过阻止靶mRNA的翻译或与之互补配对诱导靶基因降解来调控其表达。文章简要总结了microRNA-181(miR-181)在动物细胞增殖、凋亡和分化中的作用和调控机制,探讨了miR-181对淋巴细胞的增生分化、自身免疫、炎症和抗病毒等方面的免疫调控作用,并简要分析了miR-181在肿瘤发生发展、诊断、治疗和预后等方面的功能与价值,最后对miR-181的应用前景进行了探讨。研究miR-181家族成员的功能对于理解生命活动机制、疾病发生发展和找到诊治相关疾病的新方法等都具有重要的意义。 MicroRNAs (miRNAs) are a type of non-coding RNAs which are short (17-25nt) and highly conservative in evolution. They can regulate gene expression by preventing target mRNA translation or inducing degradation via oligonu cleotides complementary to target mRNA. Here, we briefly summarize the functions and regulatory mechanisms of mi croRNA-181 (miR-181) in cell proliferation, apoptosis and differentiation, and discuss the miR-181-mediated regulation of immune response in lymphocyte proliferation and differentiation, autoimmunity, inflammation and virus infection. Also, we analyze the functions of miR-181 in tumorigenesis, tumor development, diagnosis, treatment and prognosis. Finally, we discuss the application prospects of miR-181. The functional studies of miR-181 family members have important signifi cance in understanding the mechanisms of biological events, pathogenesis of diseases, and finding new ways to diagnose and treat related diseases.
出处 《遗传》 CAS CSCD 北大核心 2014年第2期103-110,共8页 Hereditas(Beijing)
基金 黑龙江省自然科学基金项目(编号:C201135) 哈尔滨市科技创新人才研究专项基金(编号:2012RFQXN005) 黑龙江省高校科技创新团队研究计划(编号:KJTD-2011-2) 哈尔滨师范大学科技发展预研项目(编号:12XYG-08)资助
关键词 microRNA-181 细胞增殖 分化 免疫 肿瘤 microRNA-181 cell proliferation differentiation immune tumor
  • 相关文献

参考文献2

二级参考文献40

  • 1Phelan D R,Price G,Liu Y F,et al.Activated JNK phosphorylates the c-terminal domain of MLK2 that is required for MLK2-induced apoptosis. Journal of Biological Chemistry . 2001
  • 2Bartel DP.MicroRNAs: genomics, biogenesis, mechanism and function. Cell . 2004
  • 3Tran SE,Holmstrom TH,Ahonen M,Kahari VM,Eriksson JE.MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. Journal of Biological Chemistry . 2001
  • 4Robinson MJ,Cobb MH.Mitogen-activated protein kinase pathways. Current Opinion in Cell Biology . 1997
  • 5Lowenberg B,Downing JR,Burnett A.Acute myeloid leukemia. New England Journal of Medicine, The . 1999
  • 6Whitman S P,Archer K J,Feng L,et al.Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Research . 2001
  • 7Xie X,Lu J,Kulbokas EJ,et al.Systematic discovery of regulatory motifs in human promoters and 3’UTRs by comparison of several mammals. Nature . 2005
  • 8Lewis B P,Burge C B,Bartel D P.Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell . 2005
  • 9Wheatley K,Burnett AK,Goldstone AH eta1.A simple,robust,validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukemia derivedfrom the MRC AML 10 trial.United Kingdom Medical Research Council‘ s Adult and Childhood Leukemia Working Parties. British Journal of Haematology . 1999
  • 10Kottaridis P D,Gale R E,Frew M E,et al.The presence ofa Flt-3internal tandem duplication in patients with acutemyeloid leukemia(AML)adds important prognosticinformation to cytogenetic risk group and response to the firstcycle of chemotherapy:. Blood . 2001

共引文献28

同被引文献11

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部